| High surface-area lyophilized compositions comprising arsenic for oral … |
2023-8-10 |
2023-8-31 |
|
| Rara agonists for the treatment of aml and mds |
2023-5-16 |
2023-6-08 |
|
| Inhibitors of cyclin‑dependent kinase 12 (cdk12) |
2022-11-18 |
2023-5-25 |
|
| METHODS OF STRATIFYING PATIENTS FOR TREATMENT WITH RETINOIC ACID RECEPTOR-α … |
2022-10-11 |
2022-12-13 |
|
| Inhibitors of cyclin-dependent kinase 7 (CDK7) |
2022-10-06 |
2022-11-03 |
|
| Compositions and methods for treating lymphomas with a cdk7 inhibitor in … |
2022-8-03 |
2023-2-09 |
|
| Compounds for the modulation of myc activity |
2022-7-13 |
2023-5-11 |
|
| Methods of treating cancer in biomarker-identified patients with inhibitors of … |
2022-4-26 |
2022-6-01 |
|
| Inhibitors of cyclin dependent kinase 7 (cdk7) |
2022-3-04 |
2022-9-29 |
|
| Treatment regimens with fixed doses of tamibarotene |
2022-1-07 |
2022-7-14 |
|
| Dosing regimens for cyclin‑dependent kinase 7 (cdk7) inhibitors |
2021-10-15 |
2022-4-21 |
|
| Compounds for the modulation of myc activity |
2021-8-25 |
2022-2-17 |
|
| Therapies for treating aml and uses of rara agonists, hypomethylating agents, … |
2021-8-06 |
2023-4-01 |
|
| Methods of stratifying patients for treatment with retinoic acid receptor-alpha … |
2021-6-01 |
2021-9-16 |
|
| Inhibitors of cyclin-dependent kinase 7 (cdk7) |
2021-5-31 |
2021-10-29 |
|
| Methods of treating cancer in patients with an anomalous kras gene or deletions … |
2021-5-28 |
2022-1-06 |
|
| Inhibitors of cyclin-dependent kinase 7 (CDK7) |
2021-5-13 |
2021-6-10 |
|
| Compounds for the modulation of myc activity |
2020-11-30 |
2021-7-22 |
|
| Inhibitors of cyclin-dependent kinase 7 (cdk7) |
2020-11-13 |
2021-3-04 |
|
| Compositions and methods for treating sickle cell disease |
2020-11-06 |
2022-6-09 |
|
| Pyrrolotriazine compounds and methods of inhibiting tam kinases |
2020-10-22 |
2021-5-20 |
|
| Inhibitors of cyclin-dependent kinase 7 (cdk7) |
2019-11-01 |
2020-10-01 |
|
| CYCLINE-DEPENDENT KINASE INHIBITORS 7 (CDK7) |
2019-11-01 |
2021-6-30 |
|
| Inhibitors of cyclin-dependent kinase 7 (CDK7) |
2019-4-23 |
2019-5-16 |
|
| Inhibitors of cyclin-dependent kinase 7 (CDK7) |
2019-1-16 |
2020-8-20 |
|
| Inhibitors of cyclin-dependent kinase 7 (cdk7) |
2019-1-04 |
2019-3-08 |
|
| Heteroaromatic compounds useful for the treatment of proliferative diseases |
2018-12-05 |
2019-8-08 |
|
| Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
2018-8-01 |
2021-2-02 |
2021-2-02 |
| Tam kinase inhibitors |
2018-7-13 |
2020-5-20 |
|
| Compositions and methods for treating cancers with covalent inhibitors of … |
2018-6-12 |
2018-12-20 |
|
| Tam kinase inhibitors |
2018-4-13 |
2020-3-05 |
|
| Compositions of cyclin-dependent kinase 7 (cdk7) inhibitor |
2018-4-03 |
2018-10-11 |
|
| METHODS OF TREATING PATIENTS WITH A RETINOIC ACID RECEPTOR-α AGONIST AND AN … |
2018-1-23 |
2018-7-26 |
|
| Methods of treating patients with a retinoic acid receptor-alpha agonist and an … |
2017-10-06 |
2018-4-12 |
|
| Methods and systems for evaluating genes |
2014-3-14 |
2016-2-04 |
|